CM Life Sciences II, a special-purpose acquisitions company (SPAC) focused on life sciences, announced on 22 March it has signed an agreement to merge with Boulder, CO-based SomaLogic, Inc., a proteomics technology platform company.
CM Life Sciences, led by affiliates of institutional investors Casdin Capital LLC and Corvex Management, could combine with SomaLogic, a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?